Key word index (vol. 6)

Diabetes Research and Clinical Practice. 6 ( 1989) 3 15-3 19

315

Elsevier

Key Word Index to Volume 6 (1989)

Cardiac

Aging - Sucrose. kinetics; Amino

dietary;

Very-low-density

Rat plasma.

lipoprotein

185

acids

- Fibres: Lipids; Insulin-dependent Anaerobic

diabetes

mellitus.

149

Lactic acid: Insulin;

Gluca-

Insulin-dependent

diabetes

mellitus:

Insulin

mellitus,

Isometric

exercise; Heart

rate variation.

mellitus; In-

Hyperinsulinemia.

exogenous;

rhythm

Combined

157

synthesis;

S I7

Insulin

insulin-sulfonylurea

Secondary

Autoradiography

failure;

release;

Transplantation,

therapy

Non-insulin-dependent

diabetes

melli-

tus. s33

- Lens soluble proteins;

Glycation;

2-D electrophoresis,

233

Concanavalin

A

NOD mice; Suppressor Cyclosporin

BB rat Diabetes mellitus; ropathy. 279

Hypoglycemia;

Insulin;

Peripheral

- Transplantation;

neu-

Delivery

B-cell capacity Urinary C-peptide. 24-h; Glycemic nopathy, proliferative, 45

control;

Diabetic

reti-

Pancreatic

Intensified

conventional

insulin treatment,

Diabetes

Intensified

conventional

insulin treatment.

271 Diabetes

- Non-insulin-dependent Americans;

diabetes Japanese.

mellitus:

Plasma

insulin;

I21

Insulin abuse,

cose tolerance

test, 89

glucose

Calmodulin Insulin receptor;

Ol68-8227/89/$03.50

Hexose transport;

((1 1989 Elsevier Science Publishers

B.V. (Biomedical

Division)

BB rat, 279 Sensitivity,

beat-to-beat

release.

variation;

early phase;

Dia-

Oral glu-

early borderline;

tolerance

W-7. 109

Insulin

light reflex; Cardiac

betes mellitus,

Naurua:

borderline

light reflex; Cardiac

mellitus.

neuropathy;

Micro-Bumintest:

early:

- Pupillary

I45

S3

199

Insulin; Peripheral

betes mellitus, Diabetes

Brain atrophy Hypoglycemia;

mellitus.

- Pupillary

Body mass index

177

Insulin pharmacodynamics.

fetal; Morphometry.

Microalbuminuria;

- Blood rheology; 259

B cell; Prednisolone.

mellitus

- Hypoglycemia;

Blood viscosity

265

route

- Rat intestine,

- Blood viscosity: 259

T-cells; Flow cytometry,

- Insulin pharmacokinetics; Development

Blood rheology

- Insulin;

in plasma;

- Islet; Insulin 139

neuropathy mellitus;

diabetes

Cold storage

malnutrition-related.

75 Diabetes

Dia-

Rat, 247

Insulin needs; Insulin action, Diabetes

borderline;

early phase: Oral glu-

feeding

Circadian

Lipids, 27

Islet cell antibody:

Japanese

pancreas:

- Lipoproteins Rat, 221

Atherosclerosis

Autonomic

test, 89

Cholesterol

69

- Exercise; Autoimmunity

cose tolerance

mellitus,

release,

~ Apolipoprotein B; Insulin-dependent sulin infusion, 69

B

Cholesterol; infusion,

early; Insulin

Cholesterol

gon. 303 Apolipoprotein

betes mellitus,

-. Embryonic

of exercise; Glucose;

variation

light reflex; Diabetes

Cell differentiation

threshold

Intensity

beat-to-beat

- Pupillary

triglyceride

test. 89

beat-to-beat

Insulin

variation;

Dia-

release, early phase: Oral

316 Diabetes Diabetic

Heart

mellitus. malnutrition-related

Islet cell antibody;

Autoimmunity,

retinopathy,

Urinary

C-peptide.

24-h; Glycemic

control.

Insulin-dependent

8-N-N-Diethylamino - Pancreatic

hormones;

Trifluoperazine;

Islet transplantation,

Glycation:

Autoradiography.

233

Epidemiology,

Calmodulin:

W-7. 109

differentiation:

X-N-N-Diethylamino

octyl 3.4,5-tri-

Norepinephrine,

227

radical

Hyperinsulinemia,

Islet transplantation,

exogenous;

Lipoproteins

167 in plasma;

Choles-

Hypoglycemia

Rat, 247

Diabetes 279

cell

Insulin binding;

I I5

Glucose,

mellitus;

Insulin; Peripheral

Insulin abuse: Brain atrophy.

Epidemiology Insulin-dependent Retinopathy;

173

terol feeding: Rat. 221

pancreas

Endothelial

mellitus:

Trifluoperazine;

Dimcthylthiourea:

2-D Electrophoresis Embryonic

hormones;

methoxybenzoate:

I67

Hydroxyl Lens soluble proteins:

exer-

6-Hydroxydopamine Pancreatic

radical;

diabetes

Insulin; Insulin receptor;

6-Hydroxydopa-

227

Dimethylthiourea Hydroxyl

Isometric

Hexose transport

octyl 3,4,5-trimethoxybenzoate

mine: Norepinephrine.

neuropathy:

Height

45

-Cell

mellitus; Autonomic

cise, 157

proliferative

B-cell capacity:

rate variation Diabetes

75

diabetes

Diabetes

mellitus;

mellitus,

Height.

BB rat,

I45

173 Immunoassay

129

Monoclonal lets. 9

Exercise Atherosclerosis:

neuropathy:

Lipids. 27

antibody;

Insulin;

Immunohistochemistry:

Is-

Immunohistochemistry -- Insulin-dependent

Fibres Amino

acids; Lipids; Insulin-dependent

diabetes

mellitus,

Target

antigen.

Monoclonal

149

Impaired

Flow cytometry ~ NOD mice; Suppressor

T-cells; Concanavalin

A, 265

Freezing

antibody;

Mathematical 17

Insulin;

Immunoassay:

Islets. 9

Insulin sensitivity,

diabetic

tosterone;

S25

Islet cell antibody;

model; Insulin secretion;

Streptozotocin Recent advances.

mellitus;

glucose tolerance

Impotence,

Insulin release; Islet cells, rat, 243 Future possibilities _ Insulin therapy;

diabetes

I61

diabetic

Testicular

rats; NOD mice; Plasma

dysfunction

free tes-

297

Incretin Castro-intestinal

hormones

-- Sulfonylurea:

Sulfonylurea:

Incretin.

Serum-free

Glucagon Anaerobic

threshold:

acid; Insulin, Glucagon

Intensity

of exercise: Glucose:

Lactic

culture:

Insulin secretion, Anaerobic

Somatostatin

rinic receptor; Glucose _ Anaerobic

hormones.

83

Insulinoma

cells: Growth

stimulants;

I

Insulin

303

release

- Insulin;

release; Nicotinic

Islet of Langerhans.

receptor;

Musca-

53

threshold;

acid: Glucagon, Diabetes

Intensity

of exercise: Glucose;

Lactic

303

mellitus:

Hypoglycemia:

Peripheral

neuropathy;

BB rat. 279 threshold;

Intensity

sulin; Glucagon. 303 _ Insulin binding; Endothelial

of exercise; Lactic acid; In-

Glucagon Muscarinic

I I5

cell.

release: Somatostatin receptor;

Insulin receptor:

Glycation

Monoclonal

Lens soluble proteins;

2-D electrophoresis:

Autorddiogra-

phy. 233 Glycemic

Gastro-intestinal

In-R I-I IO cells

83

Hexose transport:

antibody;

istry: Islets, 9

control Urinary

athy, proliferative.

45

Growth stimulants Serum-free culture; I

C-peptide.

24-h; Diabetic

retinop-

Hypoglycemia: Insulin action

Brain atrophy.

Insulin needs: Circadian Insulinoma

cells; In-RI-II0

cells; In-

Insulm binding Endothelial

cell; Glucose,

rhythm, I I5

145 Si7

receptor;

53

Calmodulin;

Immunoassay;

Insulin abuse

B-cell capacity;

sulin secretion.

release; Nicotinic

Islet of Langerhans.

W-7, 109

Immunohistochem-

317 Insulin-dependent

diabetes

- Cholesterol;

mellitus

Apolipoprotein

Fibres: Amino

B; Insulin infusion,

acids; Lipids,

Height;

Epidemiology,

Insulin

regimens;

Insulin-like growth factor I receptor _ Insulin-like growth factor I; Non-insulin-dependent

69

149

betes mellitus.

173

Insulin

Insulinoma

pen: Quality

of life; Metabolic

Target antigen;

Immunohistochemistry,

Intensified

161 Osteocalcin,

237

Intensity

mellitus,

Apolipoprotein

B; Insulin-dependent

rhythm,

S17

tation,

lin-dependent

diabetes

of life; Metabolic

mellitus.

control:

Insu-

37

Delivery

route, S3

~ Insulin pharmacodynamics;

Delivery

antibody;

tochemistry.

mellitus, malnutrition-related;

Calmodulin:

diabetes I61

W-7. 109

of life; Metabolic

mellitus.

control:

Insulin-de-

37

release

- Cold storage;

Islet; Insulin synthesis:

Transplantation,

139

Isolation

diabetes

melli-

75

antigen;

Im-

receptor, Hydroxyl

radical,

167

103

exercise

Diabetes 103

release; Nicotinic

53

of islets

Isometric

tus. I91 of islets; Transplantation,

Target

release: Somatostatin

Insulin release: Transplantation,

Non-insulin-dependent

Autoimmunity.

mellitus;

Insulin release. 243

receptor: Muscarinic Islet transplantation Dimethylthiourea:

Islet cells, rat, 243 treatment;

Immunohis-

Islet of Langerhans - Insulin; Glucagon

diabetes

Insulin: Immunoassay;

Islet cells, rat

route, S3

regimens Insulin pen: Quality

Insulin release; Transplan-

9

- Freezing:

Hexose transport:

Isolation

lactic acid; Insulin; Gluca-

Insulin synthesis;

- Insulin-dependent munohistochemistry,

Insulin receptor

Insulin

Glucose;

Islet cell antibody

Insulin pharmacokinetics

Freezing;

259

I39

- Diabetes

- Insulin pharmacokinetics:

Insulin

insulin treatment Blood rheology,

threshold;

Monoclonal Quality

Insulin pharmacodynamics

pendent

In-

of exercise

Cold storage; Circadian

regimens;

~ Insulin:

stimulants:

Islet

Insulin pen Insulin

cells; Growth

gon, 303

diabetes

69

Insulin needs _ Insulin action:

Insulin

conventional

Anaerobic

infusion

Cholesterol;

Insulin

In-RI-110

I

~ Blood viscosity;

- Osteopenia: Insulin

cells

- Serum-freeculture; sulin secretion,

control. 37 _ Islet cell antibody;

dia-

95

iation.

mellitus; Autonomic

neuropathy;

Heart rate var-

I57

release, early phase

Pupillary

light reflex; Cardiac

betes mellitus.

borderline;

cose tolerance

test. 89

beat-to-beat

Diabetes

variation;

mellitus.

Dia-

early; Oral glu-

- Serum-free

culture;

stimulants,

Mathematical sensitivity,

Insulinoma

cells;

In-RI-110

model;

Impaired

glucose

tolerance;

Insulin

model;

Insu-

2-D electrophoresis;

Autoradiography,

233

Impaired

glucose

tolerance;

Insulin

in plasma;

terol feeding;

Hyperinsulinemia,

mellitus, exogenous;

149 Choles-

Rat, 221

I7

- Cold storage;

Islet: Insulin release; Transplantation,

139

Recent advances; release;

Future

possibilities,

Non-insulin-dependent

Maternal diabetes _ Rat intestine,

S25 diabetes

mellitus.

tivity, Metabolic

growth

factor

factor

I receptor,

diabetes 95

mellitus:

Insulin-like

pendent

213

Insulin secretion;

Insulin sensi-

I7 control

~ Insulin

I

- Non-insulin-dependent

fetal: Morphometry.

Mathematical model _ Impaired glucose tolerance;

Insulin therapy

growth

of exercise; Glucose;

- Exercise; Atherosclerosis, 27 _ Fibres; Amino acids: Insulin-dependent Lipoprotein

Insulin synthesis

Insulin-like

Intensity

Lipids

I

I7

- Mathematical

Insulin 191

Glycation;

cells;

Insulin sensitivity secretion,

- Anaerobic threshold; lin: Glucagon. 303 Lens soluble proteins

Insulin secretion Growth

Lactic acid

regimens; diabetes

Insulin

mellitus.

Metformin Platelet aggregation,

61

pen: Quality 37

of life; Insulin-de-

318 Plasma

Microalbuminuria _ Micro-Bumintest;

Diabetes

mellitus;

Naurua;

Sensitivity.

insulin

Non-insulin-dependent

diabetes

mellitus:

icans: Body mass index: Japanese.

271

Japanese

Amer-

I21

Platelet aggregation

Micro-Bumintest Microalbuminuria;

Diabetes

mellitus;

Naurua:

Metformin.

Sensitivity.

61

Prednisolone

271

Transplantation;

Monoclonal antibody Insulin; Immunoassay;

lmmunohistochemistry:

Pupillary

Islets. Y

Cardiac

Morphometry Rat intestine,

fetal; Development,

_ Rat intestine, Muscdrinic

fetal: Maternal

diabetes.

beat-to-beat

lint; Diabetes

199

177

B cell: Cyclosporin.

variation;

mellitus,

Oral glucose

313

Pancreatic

light reflex early;

tolerance

Diabetes Insulin

mellitus.

release,

border-

early

phase;

test, 89

receptor

Insulin; Glucagon receptor;

release: Somatostatin

Islet of Langerhans.

Quality

release; Nicotinic

53

of life

Insulin

regimens;

dependent

diabetes

Insulin

pen; Metabolic

mellitus.

control;

Insulin-

37

Naurua Microalbuminuria: Sensitivity, Neuropathy.

Diabetes

Rat intestine,

mellitus:

peripheral

~- Diabetes Nicotinic

Micro-Bumintest:

271 mellitus;

Hypoglycemia:

Insulin;

ic receptor;

release: Somatostatin

Islets of Langerhans.

release: Muscarin-

Maternal

53

Aging:

Sucrose.

dietary;

glyceride

kinetics,

I85

Insulin therapy;

- Streptozotocin

diabetic

free testosterone; Suppressor

diabetes

therapy;

Insulin-like receptor.

dysfunction.

T-cells: Concanavalin

Non-insulin-dependent fonylurea

tats; Impotence,

Testicular

growth

diabetic;

factor

Plasma

failure,

Epidemiology; insulinsul-

Secondary

S33

I: Insulin-like

growth

factor

I

191

Americans;

Body mass index; Ja-

I2 I

pendent

Future Diabetes

possibilities, mellitus.

insulinsulfonylurea

diabetes

mellitus,

Microalbuminuria; Naurua. 271 Serum-free

S25

I29

therapy:

Non-insulin-de-

S33

hormones;

methoxybenzoate;

8-N-N-Diethylamino

Trifluoperazine:

octyl 3,4,5-tri-

6-Hydroxydopamine.

Somatostatin receptor;

test

betes mellitus.

borderline;

beat-to-beat

Diabetes

mellitus.

variation; early:

DiaInsulin

Plasma Sucrose.

release, early phase, 89

diabetic

diabetes

mellitus;

Osteopenia.

237

Prednisolone,

Muscarinic

mice; Impotence,

Testicular

dysfunction,

diabetic; 297

dietary Very-low-density

lipoprotein

triglyceride

kinetics;

I85

Gastro-intestinal Suppressor T-cells Cyclosporin:

receptor;

Sulfonylurea

B cell

Transplantation:

In-

53

rats; NOD

free testosterone:

Rat plasma,

Insulin-dependent

release: Nicotinic

Islet of Langerhans,

Aging;

Osteocdlcin

stimulants:

I

Glucagon

Streptozotocin

light reflex; Cardiac

mellitus;

release

Insulin:

Oral glucose tolerance

Diabetes

cells; In-RI-1 IO cells; Growth

sulin secretion.

227

Micro-Bumintest:

culture

lnsulinoma

- Pancreatic

I77

hormones;

NOD mice; Concanavalin

Incretin,

83

A; Flow cytometry,

265

hormones

- H-N-N-Diethylamino fluoperazine: Plasma

tri-

failure

Combined

Norepinephrine

Pancreatic

lipoprotein

Sensitivity Insulin release,

Plasma insulin; Japanese

Pancreatic

Very-low-density

265

95

Insulin treatment;

Pupillary

213

Retinopathy

297

A; Flow cytometry.

mellitus: Combined

Secondary

I99

diabetes

Recent advances

NOD mice

panese.

Development,

Morphometry: Rat plasma

BB rat, 279

receptor

Insulin; Glucagon

fetal

Morphometry:

octyl 3.4,5-trimethoxybenzoate:

6-Hydroxydopamine:

Norepinephrine,

Tri227

diabetic rats; NOD dysfunction, 297

antigen Insulin-dependent

free testosterone

Streptozotocin betic; Testicular

Target

munohistochemistry, mice: Impotence,

dia-

Testicular

diabetes mellitus; Islet cell antibody;

Im-

161

dysfunction

Streptozotocin betic: Plasma

diabetic

rats; NOD mice: Impotence.

free testosterone.

297

dia-

319 Urinary

Transplantation - Cold storage;

Islet: Insulin

synthesis:

Insulin release,

~ Isolation of islets; Insulin release, 103 ~ Pancreatic B cell: Cyclosporin; Presdnisolone,

proliferative, Very-low-density

hormones:

methoxybenzoate: 227

8-N-N-Diethylamino

6-Hydroxydopamine;

24-h Glycemic

control;

Diabetic

retinopathy,

45

I77

Trifluoperazine - Pancreatic

C-peptide.

- B-cell capacity;

139

lipoprotein

Aging; Sucrose.

octyl 3,4,5-tri-

dietary;

triglyceride

kinetics

Rat plasma,

I85

Norepinephrine, W-7 Insulin; 109

Insulin

receptor:

Hexose

transport;

Calmodulin.